Table 1.
Baseline characteristics of the participants (N = 12).
| Variables | n (%) | Mean | SD |
|---|---|---|---|
| Age (years) | 57.66 | 7.40 | |
| Male | 5 (42) | ||
| Female | 7 (58) | ||
| Education | |||
| Secondary | 2 (17) | ||
| High school degree | 5 (42) | ||
| Undergraduate degree | 4 (33) | ||
| Postgraduate degree | 1 (8) | ||
| Marital status | |||
| Married | 11 (92) | ||
| Divorced | 1 (8) | ||
| Employment | |||
| Part-time employed | 2 (17) | ||
| Full-time employed | 3 (25) | ||
| Retired | 7 (58) | ||
| Family income | |||
| Barely adequate | 1 (8) | ||
| Adequate | 7 (58) | ||
| More than adequate | 4 (33) | ||
| Tumor site | |||
| Lung—non-small cell lung cancer | 5 (42) | ||
| Pancreas—exocrine pancreatic cancer | 7 (58) | ||
| Stage | |||
| III | 3 (25) | ||
| IV | 9 (75) | ||
| Metastases sitesa | |||
| Brain | 3 (25) | ||
| Liver | 4 (33) | ||
| Lymph nodes | 3 (25) | ||
| Bone | 1 (8) | ||
| Lung | 2 (17) | ||
| Pleura | 1 (8) | ||
| Cancer cachexiab | |||
| Yes | 1 (8) | ||
| No | 11 (92) | ||
| Months since diagnosis | 17.25 | 16.36 | |
| Type of treatment | |||
| Chemotherapy | 9 (75) | ||
| Radiotherapy | 4 (33) | ||
| Surgery | 2 (17) | ||
| Immunotherapy | 1 (8) | ||
| Target therapy | 5 (42) | ||
| Current treatments status | |||
| Ongoing | 12 (100) | ||
| ECOG—performance status | |||
| 0 | 4 (33) | ||
| 1 | 8 (67) | ||
| Concomitant comorbidities | |||
| Yesc | 7 (58) | ||
| No | 5 (42) | ||
a
More than one answer is possible;
b
according to EPCRC criteria;
c
types of comorbidities: hypertension (17%), diabetes (8%), osteoporosis (17%), hypercholesterolemia (8%), polyradiculopathy (8%), kidney stones (8%), anxious-depressive syndrome (8%), migraine (8%), demyelinating neuropathy (8%), gastroesophageal reflux (8%), hip vasculitis (8%). SD, standard deviation; ECOG, Eastern Cooperative Oncology Group.